This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Jul;312(4):349-50.

doi: 10.1001/jama.2014.8606.

Integrating HIV prevention into practice

Bradley M Mathers¹, David A Cooper²

Affiliations

Affiliations

¹ Kirby Institute, University of New South Wales, Sydney, Australia.
² Kirby Institute, University of New South Wales, Sydney, Australia2HIV, Immunology, and Infectious Diseases Clinical Services Unit, St Vincent's Hospital, Sydney, Australia.

PMID: 25038352
DOI: 10.1001/jama.2014.8606

Editorial

Integrating HIV prevention into practice

Bradley M Mathers et al. JAMA. 2014 Jul.

. 2014 Jul;312(4):349-50.

doi: 10.1001/jama.2014.8606.

Authors

Bradley M Mathers¹, David A Cooper²

Affiliations

¹ Kirby Institute, University of New South Wales, Sydney, Australia.
² Kirby Institute, University of New South Wales, Sydney, Australia2HIV, Immunology, and Infectious Diseases Clinical Services Unit, St Vincent's Hospital, Sydney, Australia.

PMID: 25038352
DOI: 10.1001/jama.2014.8606

No abstract available

PubMed Disclaimer

Comment on

Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial.
Mugo NR, Hong T, Celum C, Donnell D, Bukusi EA, John-Stewart G, Wangisi J, Were E, Heffron R, Matthews LT, Morrison S, Ngure K, Baeten JM; Partners PrEP Study Team. Mugo NR, et al. JAMA. 2014 Jul 23-30;312(4):362-71. doi: 10.1001/jama.2014.8735. JAMA. 2014. PMID: 25038355 Free PMC article. Clinical Trial.
HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.
Marrazzo JM, del Rio C, Holtgrave DR, Cohen MS, Kalichman SC, Mayer KH, Montaner JS, Wheeler DP, Grant RM, Grinsztejn B, Kumarasamy N, Shoptaw S, Walensky RP, Dabis F, Sugarman J, Benson CA; International Antiviral Society-USA Panel. Marrazzo JM, et al. JAMA. 2014 Jul 23-30;312(4):390-409. doi: 10.1001/jama.2014.7999. JAMA. 2014. PMID: 25038358 Free PMC article.

Similar articles

Preexposure prophylaxis for HIV--where do we go from here?
Cohen MS, Baden LR. Cohen MS, et al. N Engl J Med. 2012 Aug 2;367(5):459-61. doi: 10.1056/NEJMe1207438. Epub 2012 Jul 11. N Engl J Med. 2012. PMID: 22784041 No abstract available.
The ART of preventing HIV.
[No authors listed] [No authors listed] Nat Med. 2011 Jan;17(1):46-7. doi: 10.1038/nm0111-46. Nat Med. 2011. PMID: 21217682 No abstract available.
Preexposure chemoprophylaxis for HIV prevention.
Pimpinella G, Malgarini RB. Pimpinella G, et al. N Engl J Med. 2011 Apr 7;364(14):1373; author reply 1374-5. doi: 10.1056/NEJMc1101504. N Engl J Med. 2011. PMID: 21470024 No abstract available.
Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice.
Li J, Dufrene SL, Okulicz JF. Li J, et al. Ann Pharmacother. 2014 Apr;48(4):507-18. doi: 10.1177/1060028014520880. Epub 2014 Jan 28. Ann Pharmacother. 2014. PMID: 24473492 Review.
Antiretrovirals for HIV Exposure Prophylaxis.
Nikolopoulos G, Tsiodras S, Bonovas S, Hatzakis A. Nikolopoulos G, et al. Curr Med Chem. 2012;19(35):5924-39. Curr Med Chem. 2012. PMID: 22963555 Review.

See all similar articles

Cited by

Preference for and Efficacy of a PrEP Decision Aid for Women with Substance Use Disorders.
Meyer J, Price C, Tracey D, Sharpless L, Song Y, Madden L, Elwyn G, Altice F. Meyer J, et al. Patient Prefer Adherence. 2021 Sep 1;15:1913-1927. doi: 10.2147/PPA.S315543. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 34511887 Free PMC article.
Is Emtricitabine-Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection Safer Than Aspirin?
Kojima N, Klausner JD. Kojima N, et al. Open Forum Infect Dis. 2016 Jan 6;3(1):ofv221. doi: 10.1093/ofid/ofv221. eCollection 2016 Jan. Open Forum Infect Dis. 2016. PMID: 26949714 Free PMC article.
Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions.
Page K, Tsui J, Maher L, Choopanya K, Vanichseni S, Mock PA, Celum C, Martin M. Page K, et al. J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2(0 1):S169-75. doi: 10.1097/QAI.0000000000000641. J Acquir Immune Defic Syndr. 2015. PMID: 25978484 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information